345 related articles for article (PubMed ID: 35214012)
1. Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma.
Ramalho MJ; Loureiro JA; Coelho MAN; Pereira MC
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214012
[TBL] [Abstract][Full Text] [Related]
2. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
[TBL] [Abstract][Full Text] [Related]
3. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
[TBL] [Abstract][Full Text] [Related]
4. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization.
Rodà F; Caraffi R; Picciolini S; Tosi G; Vandelli MA; Ruozi B; Bedoni M; Ottonelli I; Duskey JT
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768820
[TBL] [Abstract][Full Text] [Related]
6. Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme.
Jena L; McErlean E; McCarthy H
Drug Deliv Transl Res; 2020 Apr; 10(2):304-318. PubMed ID: 31728942
[TBL] [Abstract][Full Text] [Related]
7. Transferrin-Targeted Liposomes in Glioblastoma Therapy: A Review.
Kawak P; Sawaftah NMA; Pitt WG; Husseini GA
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686065
[TBL] [Abstract][Full Text] [Related]
8. Targeted Glioblastoma Treatment via Synthesis and Functionalization of Gold Nanoparticles With De Novo-Engineered Transferrin-Like Peptides: Protocol for a Novel Method.
Müller Fiedler A; Medeiros M; Fiedler HD
JMIR Res Protoc; 2023 Aug; 12():e49417. PubMed ID: 37531222
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells.
Wang X; Huang X; Yang Z; Gallego-Perez D; Ma J; Zhao X; Xie J; Nakano I; Lee LJ
Curr Pharm Biotechnol; 2014; 15(9):839-46. PubMed ID: 25374033
[TBL] [Abstract][Full Text] [Related]
10. Breaching barriers in glioblastoma. Part II: Targeted drug delivery and lipid nanoparticles.
Miranda A; Blanco-Prieto MJ; Sousa J; Pais A; Vitorino C
Int J Pharm; 2017 Oct; 531(1):389-410. PubMed ID: 28801108
[TBL] [Abstract][Full Text] [Related]
11. Boosting Glioblastoma Therapy with Targeted Pyroptosis Induction.
Fang X; Chen Z; Zhou W; Li T; Wang M; Gao Y; Ma S; Feng Y; Du S; Lan P; Chen H; Wei J; Zhang S; Li Z; Liu X; Zhang H; Guo X; Luo J
Small; 2023 Jul; 19(30):e2207604. PubMed ID: 37066699
[TBL] [Abstract][Full Text] [Related]
12.
Gallego L; Ceña V
Expert Opin Drug Deliv; 2020 Nov; 17(11):1541-1554. PubMed ID: 32791861
[TBL] [Abstract][Full Text] [Related]
13. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
14. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
15. A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas.
Di Filippo LD; de Carvalho SG; Duarte JL; Luiz MT; Paes Dutra JA; de Paula GA; Chorilli M; Conde J
Mater Today Bio; 2023 Jun; 20():100671. PubMed ID: 37273792
[TBL] [Abstract][Full Text] [Related]
16. Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers.
Liang R; Wu C; Liu S; Zhao W
Drug Deliv; 2022 Dec; 29(1):1620-1630. PubMed ID: 35612318
[TBL] [Abstract][Full Text] [Related]
17. Recent Advancements and Strategies for Overcoming the Blood-Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma.
Tincu Iurciuc CE; Andrițoiu CV; Popa M; Ochiuz L
Polymers (Basel); 2023 Oct; 15(19):. PubMed ID: 37836018
[TBL] [Abstract][Full Text] [Related]
18. Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier.
Sharma RK; Calderon C; Vivas-Mejia PE
Front Med Technol; 2021; 3():678593. PubMed ID: 35047931
[TBL] [Abstract][Full Text] [Related]
19. Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma Growth.
Salzano G; Zappavigna S; Luce A; D'Onofrio N; Balestrieri ML; Grimaldi A; Lusa S; Ingrosso D; Artuso S; Porru M; Leonetti C; Caraglia M; De Rosa G
J Biomed Nanotechnol; 2016 Apr; 12(4):811-30. PubMed ID: 27301207
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional PLGA nanoparticles combining transferrin-targetability and pH-stimuli sensitivity enhanced doxorubicin intracellular delivery and in vitro antineoplastic activity in MDR tumor cells.
Scheeren LE; Nogueira-Librelotto DR; Mathes D; Pillat MM; Macedo LB; Mitjans M; Vinardell MP; Rolim CMB
Toxicol In Vitro; 2021 Sep; 75():105192. PubMed ID: 33984456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]